These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3028951)

  • 21. A case/control study of hepatitis B virus serologic markers in Senegalese patients suffering from primary hepatocellular carcinoma.
    Coursaget P; Maupas P; Goudeau A; Chiron JP; Raynaud B; Drucker J; Barin F; Denis F; Diop Mar I; Diop B
    Prog Med Virol; 1981; 27():49-59. PubMed ID: 6262871
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatitis B surface antigen and alpha-1-fetoprotein in hepatoma. Reports of 157 cases.
    Pongpipat D; Suvatte V; Plengvanit U; Chinapak O; Bunyaphisit S; Assateerawatts A
    J Med Assoc Thai; 1983 Nov; 66(11):696-9. PubMed ID: 6200559
    [No Abstract]   [Full Text] [Related]  

  • 23. Australia antigen in liver disease in Zambia.
    Lowenthal M; Banatvala JE; Chrystie IL; Jones IG; Nag J; Mohelsky V; Hutt MS
    Trop Geogr Med; 1973 Mar; 25(1):39-44. PubMed ID: 4348424
    [No Abstract]   [Full Text] [Related]  

  • 24. Primary hepatocellular carcinoma with hepatitis B virus infection in a 16-year-old noncirrhotic patient.
    Gasser RW; Judmaier G; Zur Nedden D; Aufschnaiter M; Hofstaedter F
    Am J Gastroenterol; 1983 May; 78(5):305-8. PubMed ID: 6189392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of HBeAg in the lymphocytes of sero-HBeAg negative patients with chronic hepatitis B and primary hepatocellular carcinoma.
    Ding JL; Oon CJ
    Cytobios; 1984; 39(153):29-33. PubMed ID: 6323101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma and type B hepatitis.
    Hadziyannis SJ
    Clin Gastroenterol; 1980 Jan; 9(1):117-34. PubMed ID: 6249525
    [No Abstract]   [Full Text] [Related]  

  • 27. Localization of hepatitis B virus antigens in hepatocellular carcinoma.
    Nazarewicz-de Mezer T; Slusarczyk J; Krawczynski K; Nowoslawski A
    Prog Med Virol; 1981; 27():66-76. PubMed ID: 6262874
    [No Abstract]   [Full Text] [Related]  

  • 28. Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies.
    Shikata T; Uzawa T; Yoshiwara N; Akatsuka T; Yamazaki S
    Jpn J Exp Med; 1974 Feb; 44(1):25-36. PubMed ID: 4363514
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatocellular carcinoma: a review of the recent studies and developments.
    Okuda K; Nakashima T
    Prog Liver Dis; 1979; 6():639-50. PubMed ID: 232282
    [No Abstract]   [Full Text] [Related]  

  • 30. [Morphological demonstration of hepatitis B virus surface antigen in liver cirrhosis, fibrosis and hepatocellular carcinoma (author's transl)].
    Chlumská A; Kautzner J
    Cas Lek Cesk; 1981 Jun; 120(23):689-92. PubMed ID: 6265089
    [No Abstract]   [Full Text] [Related]  

  • 31. Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver.
    Hirohashi S; Shimosato Y; Ino Y; Kishi K
    J Natl Cancer Inst; 1982 Sep; 69(3):565-8. PubMed ID: 6287080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relation between the pathologic grading and the distribution of HBAg in hepatocellular carcinoma].
    Wang WL
    Zhonghua Zhong Liu Za Zhi; 1983 Jan; 5(1):31-3. PubMed ID: 6189684
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatitis B virus infection and hepatocellular carcinoma: indication for a possible causal connection even in non-endemic Switzerland].
    Pirovino M; Heer M; Altorfer J; Akovbiantz A; Grob P; Schmid M
    Schweiz Med Wochenschr; 1983 Jun; 113(22):824-6. PubMed ID: 6192495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis B virus surface antigen (HBSAG) and primary liver carcinoma: a retrospective study].
    Sarno EN; Vieira LM; Faulhaber DM
    Rev Inst Med Trop Sao Paulo; 1980; 22(1):20-3. PubMed ID: 6254134
    [No Abstract]   [Full Text] [Related]  

  • 35. [Detection and follow-up of the high risk group for hepatocellular carcinoma].
    Araki E
    Gan No Rinsho; 1984 Sep; 30(11):1373-8. PubMed ID: 6094881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B viral markers in patients with chronic hepatitis and with primary hepatocellular carcinoma in Taiwan.
    Tong MJ; Chien MC; Lo KJ; Tsai YT; Lee JK
    Prog Med Virol; 1981; 27():60-5. PubMed ID: 6262873
    [No Abstract]   [Full Text] [Related]  

  • 37. Australia antigen in liver tissue--an immunofluorescent and immunoelectron microscopic study.
    Shikata T
    Jpn J Exp Med; 1973 Aug; 43(4):231-45. PubMed ID: 4354081
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Sep; 7(5):589-605. PubMed ID: 6190271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.
    Wada Y; Nakashima O; Kutami R; Yamamoto O; Kojiro M
    Hepatology; 1998 Feb; 27(2):407-14. PubMed ID: 9462638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preparation of monoclonal antibody directed against hepatitis B virus X protein and detection of reactive antigen in hepatocellular carcinoma].
    Li J; Tang ZY; Liu KD; Schroder CH
    Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):533-5, 582. PubMed ID: 7842349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.